3Bolte AC, van Geijn HP, Dekker GA. Management and monitoring of severe preeelampsia [ J ]. Eur J Obstet Gynecol Reprod Bio1,2001,96( 1 ) :8-20.
4Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term : patient selection, treatment, and delivery indications [ J ]. Am J Obstet Gynecol, 2007,196 ( 6 ) : 514e1-9.
5Haddad B, Kayem G, Deis S, et al. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growtfi restriction? [ J]. Am J Obstet Gyneco1,2007,196 ( 3 ) :237el-5.
6Hall DR, Grov D, Carstens E. Early pre-eelampsia: what proportion of women qualify for expectant management and if not, why not? [ J]. Eur J Obstet Gynecol Reprod Biol,2006, 128( 1- 2) : 169-174.
7Bloomenthal D, yon Dadelszen P, Liston R. The effect of factor V Leiden carriage on maternal and fetal health [ J ]. CMAJ, 2002,167( 1 ) :48-54.
8Steyn DW, Odendaal H J, Hall DR. Diurinal blood pressure variation in the evaluation of early onset severe pre-eclampsia [ J ]. Eur J Obstet Gynecol Reprod Biol,2008,138 (2) :141-146.
9Price CP, Newall RG, Boyd JC. Use of protein : creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review[ J]. Clin Chem, 2005,51 (9) :1577-1586.
10Keiler H, Zettergren T, Svensson H, et al. Assessing urinary albumin excretion in pre-eclamptic women : which sample to use? [J]. BJOG,2003 ,110 :12-17.
